Attached files

file filename
EX-99.1 - PRESS RELEASE DATED JANUARY 10, 2013 - BSD MEDICAL CORPexhibit99-1.htm


UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C.  20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  January 10, 2013
 
BSD MEDICAL CORPORATION
 
(Exact name of registrant as specified in its charter)
 
Delaware
0-10783
75-1590407
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

2188 West 2200 South
 
Salt Lake City, Utah 84119
 
(Address of principal executive offices, including Zip Code)
 
Registrant’s telephone number, including area code:  (801) 972-5555
 
N/A
 
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 

 
 

 

Item 2.02 Results of Operations and Financial Condition.
 
On January 10, 2013, BSD Medical Corporation (the “Company”) issued a press release reporting financial results for its fiscal quarter ended November 30, 2012.  A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.
 
(d) Exhibits.
 
Exhibit No.
 
Description
99.1
 
Press release dated January 10, 2013 regarding financial results for the fiscal quarter ended November 30, 2012

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
     BSD MEDICAL CORPORATION  
       
Date:  January 14, 2013      
     By:  /s/ William S. Barth        
     Name:  William S. Barth  
     Title:    Chief Financial Officer  
 
 
 
                                                          
 
2

 

EXHIBIT INDEX
 
Exhibit No.
 
Description
99.1
 
Press release dated January 10, 2013 regarding financial results for the fiscal quarter ended November 30, 2012

 
 
 
 
 
 
 
3